Please login to the form below

Not currently logged in
Email:
Password:

McKinsey

This page shows the latest McKinsey news and features for those working in and with pharma, biotech and healthcare.

Keeping it in the family pays dividends

Keeping it in the family pays dividends

It is clear the benefits leach into culture as a McKinsey survey of businesses owned by families and founders showed that 90% of board members said that family values were present

Latest news

  • I, Robot: How AI is redefining the use of data in healthcare I, Robot: How AI is redefining the use of data in healthcare

    McKinsey's analysis of this space has recently suggested that the use of data handling strategies for pharmaceutical research could create up to $100bn in cost savings per year, and that

  • A new era of collaboration A new era of collaboration

    A study by McKinsey found that if spending on health increases at the current rate, it will reach 50% of the GDP in most Organisation for Economic Cooperation and Development (OECD)

  • The Digital Patient The Digital Patient

    A 2014 survey from McKinsey &Co showed that three quarters of consumers in the UK, Germany and Singapore would like to make use of digital healthcare services – contrary to the perceived ... The McKinsey survey also exploded the myth that only younger

  • Novo Nordisk will work with IBM on diabetes care Novo Nordisk will work with IBM on diabetes care

    hold the key to revolutionising R&D and accelerating productivity - as laid out in a McKinsey &Co report published in 2013.

  • Teva takes controlling stake in genomics specialist Teva takes controlling stake in genomics specialist

    A 2013 report on personalised medicine by McKinsey &Co acknowledged the "tremendous potential" for this type of approach in CNS diseases whilst noting it is still in its infancy.

More from news
Approximately 0 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • Pharma funding and M&A in 2020 Pharma funding and M&A in 2020

    Indeed, McKinsey research found that between 2001 and 2016, the share of revenues coming from innovations outside Big Pharma grew from 25% to almost 50%.

  • Mapping the patient journey and minding the gap Mapping the patient journey and minding the gap

    Speaking to McKinsey in 2016, the biotech CEO argued that a new generation of patient engagement was dawning.

  • It started with a miss It started with a miss

    The facts tell a different story. Seven years after McKinsey’s much- quoted claim that around two-thirds of all new drugs fail to meet pre-launch sales expectations in their ... McKinsey agrees, claiming 75% of launches that underperform against

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    Originally trained as a doctor, Sam practised medicine in her native Australia, South Africa and the UK before joining McKinsey and eventually specialising in healthcare. ... After McKinsey she moved into the NHS as a senior manager at a large teaching

  • The rise of digital comms The rise of digital comms

    experience. Independents overtake relationship seekers. Traditionally, pharma companies targeted HCPs that were relationship seekers, as defined by McKinsey.

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE
The art of delivering valuable customer journeys aligned to your key messages in 2020...
DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...

Infographics